Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
3/7/2025 | $14.00 | Neutral → Buy | Rosenblatt |
1/31/2025 | $15.00 | Hold → Buy | Needham |
12/17/2024 | $8.00 → $9.50 | Equal-Weight → Underweight | Morgan Stanley |
11/19/2024 | $10.60 | Neutral | UBS |
6/26/2024 | $8.25 | Buy → Neutral | Rosenblatt |
5/3/2024 | $9.00 | Positive → Neutral | Susquehanna |
2/12/2024 | $10.00 → $13.00 | Hold → Buy | Stifel |
12/2/2022 | $12.00 | Hold | Stifel |
SC 13G - VIAVI SOLUTIONS INC. (0000912093) (Subject)
SC 13G/A - VIAVI SOLUTIONS INC. (0000912093) (Subject)
SC 13G/A - VIAVI SOLUTIONS INC. (0000912093) (Subject)
CHANDLER, Ariz., April 17, 2025 /PRNewswire/ -- Viavi Solutions Inc. (VIAVI) (NASDAQ:VIAV) will announce its fiscal third quarter 2025 financial results for the period ended March 29, 2025, on Thursday, May 1, 2025, after the close of market. The Company will host an earnings call at 1:30 p.m. PT / 4:30 p.m. ET. A live webcast of the call and the replay will be available on the VIAVI website at https://investor.viavisolutions.com. The quarterly earnings press release, supplementary slides and historical financial tables will be posted under the "Quarterly Results" section. To
CHANDLER, Ariz., Jan. 30, 2025 /PRNewswire/ -- VIAVI (NASDAQ:VIAV) today reported results for its second quarter ended December 28, 2024 with the following highlights. Second Quarter Net revenue of $270.8 million, up $16.3 million or 6.4% year-over-yearGAAP operating margin of 8.2%, down 60 bps year-over-yearNon-GAAP operating margin of 14.9%, up 170 bps year-over-yearGAAP net income of $9.1 million, down $1.6 million or 15.0% year-over-yearNon-GAAP net income of $29.4 million, up $5.7 million or 24.1% year-over-year GAAP diluted earnings per share (EPS) of $0.04, down $0.01 o
CHANDLER, Ariz., Jan. 16, 2025 /PRNewswire/ -- Viavi Solutions Inc. (VIAVI) (NASDAQ:VIAV) will announce its fiscal second quarter 2025 financial results for the period ended December 28, 2024, on Thursday, January 30, 2025, after the close of market. The Company will host an earnings call at 1:30 p.m. PST / 4:30 p.m. EST. A live webcast of the call and the replay will be available on the VIAVI website at https://investor.viavisolutions.com. The quarterly earnings press release, supplementary slides and historical financial tables will be posted under the "Quarterly Results" se
CHANDLER, Ariz., April 17, 2025 /PRNewswire/ -- Viavi Solutions Inc. (VIAVI) (NASDAQ:VIAV) will announce its fiscal third quarter 2025 financial results for the period ended March 29, 2025, on Thursday, May 1, 2025, after the close of market. The Company will host an earnings call at 1:30 p.m. PT / 4:30 p.m. ET. A live webcast of the call and the replay will be available on the VIAVI website at https://investor.viavisolutions.com. The quarterly earnings press release, supplementary slides and historical financial tables will be posted under the "Quarterly Results" section. To
Expansion includes new RF chamber and two additional customer labs CHANDLER, Ariz., April 3, 2025 /PRNewswire/ -- VIAVI Solutions Inc. (VIAVI) (NASDAQ:VIAV) today announced that it has expanded its VIAVI Automated Lab-as-a-Service for Open RAN (VALOR™) testing facility with an RF-shielded anechoic chamber and two additional customer labs. Based in Chandler, Arizona, the VALOR Lab offers a highly automated, open and impartial Lab-as-a-Service / Test-as-a-Service suite for Open RAN interoperability, performance and security. The project is funded by the U.S. National Telecommunications and Information Administration (NTIA) Public Wireless Supply Chain Innovation Fund.
Industry-first ONE LabPro ONE-1600 supporting high-bandwidth Ethernet testing will be showcased at OFC 2025 Honored by 2025 Lightwave+BTR Innovation ReviewsCHANDLER, Ariz., April 1, 2025 /PRNewswire/ -- Viavi Solutions Inc. (VIAVI) (NASDAQ:VIAV) today announced enhanced performance capabilities for the VIAVI ONE LabPro ONE-1600, the world's first electrical 212G/lane, 1.6Tb/s testing solution that has been proven in labs around the world. Leveraging the latest SerDes and DSP technology from Broadcom, the enhanced ONE LabPro ONE-1600 platform provides a highly advanced test platform for physical layer silicon fully aligned with emerging standards, the ability to test framed and unframed traf
Joint Framework Expands Testing Services, Driving Industry-wide Adoption of Open RAN Solutions Advancing Industry Standards Through Collaboration: TIP partners with VIAVI to expand VALOR's testing for Open RAN.Streamlined Testing: Establishes VALOR as the first TIP-authorized test lab, reducing testing duplication.Industry-wide impact: Accelerates Open RAN adoption and drives global industry alignment.CHANDLER, Ariz., July 9, 2024 /PRNewswire/ -- Viavi Solutions Inc. (VIAVI) (NASDAQ:VIAV) and the Telecom Infra Project (TIP) today announced a strategic collaboration aimed at expanding the testing capabilities of the VIAVI Automated Lab-as-a-Service for Open RAN (VALOR™). VALOR, made possible
SCOTTSDALE, Ariz., Feb. 18, 2021 /PRNewswire/ -- (NASDAQ: VIAV) Viavi Solutions Inc. ("VIAVI") announced today the appointment of Henk Derksen as Executive Vice President and Chief Financial Officer effective March 15, 2021. Mr. Derksen will report to President and Chief Executive Officer Oleg Khaykin and oversee the global finance organization, including finance, accounting and reporting, tax, treasury, internal audit, investor relations and information technology (IT). "I'm excited to have Henk join our executive team and help us execute our growth strategy." said Oleg Khaykin. "He brings extensive financial, international, and business management expertise to VIAVI, has deep familiarit
4 - VIAVI SOLUTIONS INC. (0000912093) (Issuer)
4 - VIAVI SOLUTIONS INC. (0000912093) (Issuer)
4 - VIAVI SOLUTIONS INC. (0000912093) (Issuer)
144 - VIAVI SOLUTIONS INC. (0000912093) (Subject)
8-K - VIAVI SOLUTIONS INC. (0000912093) (Filer)
SCHEDULE 13G/A - VIAVI SOLUTIONS INC. (0000912093) (Subject)
Rosenblatt upgraded Viavi from Neutral to Buy and set a new price target of $14.00
Needham upgraded Viavi from Hold to Buy and set a new price target of $15.00
Morgan Stanley downgraded Viavi from Equal-Weight to Underweight and set a new price target of $9.50 from $8.00 previously